Recent findings in genetically deficient (RAGE−/−) mice or rats treated with an anti-RAGE antibody suggest that targeting RAGE might be a beneficial therapy for treatment of experimental sepsis and pneumonia17,18. Here, AGER is linked to Sepsis.